Click here to download and analyze the case study for this week. Create a SOAP note for disease prevention, health promotion, and acute care of the patient in the clinical case. Your care plan should be based on current evidence and nursing standards of care.
Visit the online library and research for current scholarly evidence (no older than 5 years) to support your nursing actions. In addition, consider visiting government sites such as the CDC, WHO, AHRQ, Healthy People 2020. Provide a detailed scientific rationale justifying the inclusion of this evidence in your plan.
Next determine the ICD-10 classification (diagnoses). The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-10-CM) is the official system used in the United States to classify and assign codes to health conditions and related information.
Click here to access the codes.
Download the SOAP template to help you design a holistic patient care plan. Utilize the SOAP guidelines to assist you in creating your SOAP note and building your plan of care. You are expected to develop a comprehensive SOAP note based on the given assessment, diagnosis, and advanced nursing interventions. Reflect on what you have learned about care plans through independent research and peer discussions and incorporate the knowledge that you have gained into your patient’s care plan. If the information is not in the provided scenario please consider it normal for SOAP note purposes, if it is abnormal please utilize what you know about the disease process and write what you would expect in the subjective and objective areas of your note.
Week 2: Respiratory Clinical Case
65 year old Caucasian female that was discharged from the hospital 10 weeks ago after a motor vehicle
accident presents to the clinic today. States she is having severe wheezing, shortness of breath and
coughing at least once daily. She can barely get her words out without taking breaks to catch her breath
and states she has taken albuterol once today.
Frequent asthma attacks for the past 2 months (more than 4 times per week average), serious MVA 10
weeks ago; post traumatic seizure 2 weeks after the accident; anticonvulsant phenytoin started – no
seizure activity since initiation of therapy.
History of periodic asthma attacks since early 20s; mild congestive heart failure diagnosed 3 years ago;
placed on sodium restrictive diet and hydrochlorothiazide; last year placed on enalapril due to
worsening CHF; symptoms well controlled the last year.
Past Surgical History
Family: Father died age 59 of kidney failure secondary to HTN; Mother died age 62 of CHF
Social: Nonsmoker; no alcohol intake; caffeine use: 4 cups of coffee and 4 diet colas per day.
Theophylline SR Capsules 300 mg PO BID
Albuterol inhaler, PRN
Phenytoin SR capsules 300 mg PO QHS
HTCZ 50 mg PO BID
Enalapril 5 mg PO BID
Positive for shortness of breath, coughing, wheezing and exercise intolerance. Denies headache,
swelling in the extremities and seizures.
BP 171/94, HR 122, RR 31, T 96.7 F, Wt 145, Ht 5’ 3”
VS after Albuterol breathing treatment – BP 134/79, HR 80, RR 18
Gen: Pale, well developed female appearing anxious. HEENT: PERRLA, oral cavity without lesions, TM
without signs of inflammation, no nystagmus noted. Cardio: Regular rate and rhythm normal S1 and S2.
Chest: Bilateral expiratory wheezes. Abd: soft, non-tender, non-distended no masses. GU:
Unremarkable. Rectal: Guaiac negative. EXT: +1 ankle edema, on right, no bruising, normal pulses.
NEURO: A&O X3, cranial nerves intact.
Laboratory and Diagnostic Testing
Na – 134
K – 4.9
Cl – 100
BUN – 21
Cr – 1.2
Glu – 110
ALT – 24
AST – 27
Total Chol – 190
CBC – WNL
Theophylline – 6.2
Phenytoin – 17
Chest Xray – Blunting of the right and left costophrenic angles
Peak Flow – 75/min; after albuterol – 102/min
FEV1 – 1.8 L; FVC 3.0 L, FEV1/FVC 60%
Running head: NAME OF CARE PLAN 1
Title of Plan of Care
South University Online
NAME PLAN OF CARE 2
**Please delete this statement and anything in italics prior to submission to shorten the length
of your paper.
Patient Initials ______
Subjective Data: (Information the patient tells you regarding themselves: Biased Information):
Chief Compliant: (In patient’s exact words)
History of Present Illness: (Analysis of current problems in chronologic order using symptom
analysis [onset, location, frequency, quality, quantity, aggravating/alleviating factors, associated
symptoms and treatments tried]).
PMH/Medical/Surgical History: (Includes medications and why taking, allergies, other major
medical problems, immunizations, injuries, hospitalizations, surgeries, psychiatric history,
obstetric and history sexual history).
Significant Family History: (Includes family members and specific inheritable diseases).
Social History: (Includes home living situation, marital history, cultural background, health
habits, lifestyle/recreation, religious practices, educational background, occupational history,
financial security and family history of violence).
Review of Symptoms: (Review each body system – This section you should place POSITIVE for…
information in the beginning then state Denies…). – General:; Integumentary:; Head:; Eyes: ;
ENT:; Cardiovascular:; Respiratory: ; Gastrointestinal:; Genitourinary:; Musculoskeletal:;
Neurological:; Endocrine:; Hematologic:; Psychologic: .
Vital Signs: BP – ; P ; R ; T ; Wt. ; Ht. ; BMI .
Physical Assessment Findings: (Includes full head to toe review)
Laboratory and Diagnostic Test Results: (Include result and interpretation.)
Assessment: (Include at least 3 priority diagnosis with ICD-10 codes. Please place in order of
Plan of Care: (Addressing each dx with diagnostic and therapeutic management as well as
education and counseling provided).
NAME PLAN OF CARE 3
Running head: RESPIRATORY CLINICAL CASE 1
RESPIRATORY CLINICAL CASE 2
Respiratory Clinical Case
South University Online
Dr. Judith Cornelius
Patient Initials: CF Gender: Female Age: 65
Patient comes to the clinic with the chief complaints of shortness of breath, wheezing and mild coughing.
For the last 2 months, patient has experienced asthma attacks on average more than 4 times a week, posttraumatic seizure 2 weeks after the accident and serious MVA 10 weeks ago. Anticonvulsant phenytoin started recently and there has not been any seizure activity since the initiation of therapy.
Patient has a history of periodic asthma attacks dating back to her early 20s. Three years ago, patient was diagnosed with mild congestive heart failure and placed on hydrochlorothiazide and sodium restrictive diet. Last year, CF placed on enalapril because of worsening CHF. Medication has controlled the symptoms relatively well the last year. Apart from enalapril, other medications prescribed for the patient include albuterol inhaler, theophylline SR capsules 300 mg PO BID, and PRN Phenytoin SR capsules 300 mg PO QHS. She has no known allergies. Patient has not had any surgeries.
The patient’s parents are both deceased. Her father succumbed to kidney failure at age 59 while her mother died of CHF aged 62
Patient attests that she is a nonsmoker and she does not consume alcohol. She takes four cups of diet colas and the same number of coffee cups
Positive for cough, wheezing, exercise intolerance and shortness of breath. Denies seizures, headaches and swelling of extremities
Pale, well-developed Caucasian female appearing to be anxious. HEENT: PERRLA, oral cavity without lesions, TM without signs of inflammation, no nystagmus noted. Abdomen: non-tender, soft, non-distended no masses. Chest: Bilateral expiratory wheezes. Cardio: Regular rate and rhythm normal S1 and S2. Rectal: Guaiac negative. GU: Unremarkable. NEURO: A&O X3, cranial nerves intact. EXT: +1 ankle edema, on right, no bruising, normal pulses.
Vital Signs: BP 171/94, HR 122, RR 31, T 96.7 F, Wt 145, Ht 5’ 3”. After the albuterol treatment, vital signs are BP 134/79, HR 80, and RR 18
Physical Assessment and Diagnostic Testing: Na – 134, K – 4.9, Cl – 100 (all within normal limits), BUN – 21, Cr – 1.2, Glu – 110, Theophylline – 6.2, Phenytoin – 17, ALT – 24, AST – 27, Total Chol – 190 (substantially high, predicted moderate restriction). CBC – WNL, Chest Xray – Blunting of the left and right costophrenic angles, Peak Flow – 75/min (relatively low, normal should be between 80-100/min); after albuterol – 102/min, FEV1 – 1.8 L; FVC 3.0 L, FEV1/FVC 60% (predicted moderate obstruction).
1. Chronic obstructive asthma J44.9 (CMS.gov, 2016). Presenting symptoms that match this diagnosis include wheezing, cough, dyspnea/shortness of breath, cough and +1 ankle edema. Previous asthma attacks also place the patient at increased risk of contracting chronic obstructive asthma
2. Emphysema, unspecified J43.9 (CMS.gov, 2016), as evidenced by the patient’s shortness of breath, cough, low FEV1/FVC 60%
3. Bronchitis not specified as acute or chronic. J40 (CMS.gov, 2016) as indicated by the occasional cough, shortness of breath and bilateral expiratory wheezes
A comprehensive care plan targeting the identified diagnoses will help in improving patient care outcomes for the 65-year-old Caucasian female. Patient must receive appropriate instruction pertaining to the possible diagnoses identified. Asthma can be a life threatening condition that causes inflammation and swelling of the airways, making it difficult to breathe. Environmental and genetic factors may play a role in asthma attacks. Bellia & Incalzi (2012) contend that other risks such as air pollution, stress and allergies can trigger asthma attacks. Emphysema on the contrary is a lung disease characterized by reduced airflow and inflammation in the lungs. The reduced airflow results in gradual destruction of the small sacs in the lungs, subsequently manifesting symptoms such as shortness of breath, chest tightness, fatigue, a chronic cough and wheezing. Major risk factors for developing emphysema include smoking, exposure to air pollution and alpha-1-antitrypsin (ATT) deficiency (Buttaro, Trybulski, Bailey, & Sandberg-Cook, 2013). Bronchitis is also a serious lung disease that occurs due to bronchial tubes’ inflammation. The most common cause of the condition is cold virus, but bacteria can also be the cause in some cases.
The treatment plan prioritizes medications as well as other non-pharmacological interventions. Anticipated outcomes include patient demonstrating improved oxygenation and ventilation, exhibiting effective breathing patterns, maintaining respiratory rate within normal limits and increased control of inflammatory episodes. According to Buttaro et al. (2013), the first line medication for asthma is albuterol, inhaled 1 to 2 puffs every 4 to 6 hours when the patient has breathing complications. Similarly, for emphysema, the primary medication used for reducing dyspnea and improving exercise tolerance is albuterol. Dosage approved by the FDA is 400 µg inhaled twice daily (Bellia & Incalzi, 2012). Other medications to prescribe to the patient will include metaproterenol and levalbuterol (0.2 to 0.3 mL of 5% solution). The medications target various reversible airflow limitations including bronchial smooth muscle contraction, increased airway secretions, bronchial mucosal congestion and airway inflammation. Various medications are also effective for treating bronchitis. Apart from albuterol, the other effective drug for managing the condition is amoxicillin 80 to 90 mg per kg per day taken orally.
Complementary and alternative medicines will also be part of the care plan. Various studies have indicated the efficacy of some herbal remedies in the management of pulmonary conditions such as asthma, bronchitis and emphysema. For example, in a study conducted by Akinci, Zengin, Yildiz, Sener, & Gunaydin (2011), the researchers found out that the most common and effective CAM methods utilized by the participants included deep inhalation, applying vapor, praying and herb or herbal tea. Generally, the patients in this study used CAM to relax, reduce dyspnea, breath comfortably and improve respiration. The researchers also established that these CAM methods had little to no negative side effects (Akinci et al., 2011). Because of the efficacy and safety of the herbal remedies, practitioner will consult with patient to ascertain whether she could implement any of the methods in combination with the medications prescribed. Consulting with the patient also aids practitioner to provide culturally congruent care.
Patient will also receive education on self-care practices that can aid to improve her condition. As the European Respiratory Society (2013) points out, self-care should entail avoiding secondhand smoke, avoiding smoke from fireplaces and avoiding exposure to very cold air. It is also paramount to instruct the patient about the proper use of cough suppressants, OTC fever reducers and pain relievers. Practitioner will further enlighten the patient about the importance of using forward-leaning postures in addition to learning controlled breathing techniques such as purse-lip breathing and abdominal muscle breathing (diaphragmatic breathing). Practitioner will also evaluate the patient’s knowledge pertaining to the use, care and cleansing of nebulizer and inhaler use. According to Bellia & Incalzi (2012), contaminated DPIs, MDIs, diskus, turbuhaler and nebulizer equipment are typical causes of infections.
Apart from the practitioner, other helping professionals will also provide care to the patient. For example, human service professionals will help patient in looking for possible assistance/community resources while spiritual leaders will offer nourishment to ensure that the patient receives holistic care. Referring the patient to psychiatric specialists is another component of the care plan that will help ease her anxiety and mild stress. Involving CF’s family members is also critical. Buttaro et al. (2013) acknowledge that warmth and cohesiveness in the family environment improves resiliency and provides a coping mechanism for the patient.
Follow-up will entail appropriate monitoring of patient’s vital signs following discharge. First follow up scheduled after 4 weeks. During the session, practitioner will conduct comprehensive physical examinations and diagnostic tests including spirometry, methacholine challenge test and chest x-rays to check the prognosis of disease (European Respiratory Society, 2013). Patient to share information about any side effects or allergies associated with the medications she is taking. Appropriate measures will be taken to ensure adherence, compliance and improved outcomes.
Akinci , A., Zengin , N., Yildiz , H., Sener , E., & Gunaydin , B. (2011). The complementary and alternative medicine use among asthma and chronic obstructive pulmonary disease patients in the southern region of Turkey. International Journal of Nursing Practiceq, 17(6), 571-582.
Bellia, V., & Incalzi, R. (2012). Respiratory diseases in the elderly (3 ed.). Sheffield: European Respiratory Society Journals.
Buttaro, T., Trybulski, J., Bailey, P., & Sandberg-Cook, J. (2013). Primary care : a collaborative practice (4 ed.). St. Louis, Mo.: Elsevier/Mosby.
CMS.gov. (2016). ICD-10. Retrieved from https://www.cms.gov/medicare/coding/icd10/index.html
European Respiratory Society. (2013). Respiratory diseases in the world: Realities of today – opportunities for tomorrow. Retrieved February 12, 2017, from https://www.ersnet.org/pdf/publications/firs-world-report.pdf
We are a professional custom writing website. If you have searched a question and bumped into our website just know you are in the right place to get help in your coursework.
Yes. We have posted over our previous orders to display our experience. Since we have done this question before, we can also do it for you. To make sure we do it perfectly, please fill our Order Form. Filling the order form correctly will assist our team in referencing, specifications and future communication.
2. Fill in your paper’s requirements in the "PAPER INFORMATION" section and click “PRICE CALCULATION” at the bottom to calculate your order price.
3. Fill in your paper’s academic level, deadline and the required number of pages from the drop-down menus.
4. Click “FINAL STEP” to enter your registration details and get an account with us for record keeping and then, click on “PROCEED TO CHECKOUT” at the bottom of the page.
5. From there, the payment sections will show, follow the guided payment process and your order will be available for our writing team to work on it.
Need this assignment?
Order here and claim 25% off
Discount code SAVE25